gptkbp:instanceOf
|
gptkb:drug
|
gptkbp:affects
|
gptkb:Central_nervous_system
|
gptkbp:alsoKnownAs
|
Central nervous system depressants
|
gptkbp:cause
|
gptkb:Overdose
Addiction
Dependence
Respiratory depression
|
gptkbp:effect
|
Cause drowsiness
Impair cognitive function
Induce relaxation
Reduce arousal
Reduce stimulation
|
gptkbp:example
|
gptkb:beer
gptkb:Carisoprodol
gptkb:Benzodiazepines
gptkb:Z-drugs
gptkb:Barbiturates
gptkb:Opioids
gptkb:Chloral_hydrate
gptkb:Meprobamate
gptkb:Quaaludes
GHB
|
https://www.w3.org/2000/01/rdf-schema#label
|
Depressants
|
gptkbp:legalStatus
|
Controlled substances (varies by country)
|
gptkbp:mechanismOfAction
|
Enhance GABA activity
Inhibit glutamate activity
|
gptkbp:medicalUse
|
gptkb:Anesthesia
Anxiety treatment
Insomnia treatment
Muscle relaxation
Seizure control
|
gptkbp:overdoseSymptoms
|
gptkb:Coma
death
Slowed breathing
|
gptkbp:riskFactor
|
Tolerance
Memory impairment
Drug interactions
Withdrawal syndrome
Impaired motor skills
|
gptkbp:routeOfAdministration
|
gptkb:Oral
Intravenous
Inhalation
|
gptkbp:usedFor
|
Pain relief
Sedation
Anxiolysis
Muscle relaxation
Sleep induction
|
gptkbp:withdrawalSymptoms
|
gptkb:Anxiety
gptkb:Delirium_tremens
Seizures
|
gptkbp:bfsParent
|
gptkb:Schedule_I_(US)
|
gptkbp:bfsLayer
|
6
|